These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23689727)

  • 1. Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.
    Huyen MN; Cobelens FG; Buu TN; Lan NT; Dung NH; Kremer K; Tiemersma EW; van Soolingen D
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3620-7. PubMed ID: 23689727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.
    Pinhata JMW; Brandao AP; Mendes FF; Rabello MCDS; Ferrazoli L; de Oliveira RS
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2551-2561. PubMed ID: 34297229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    BMC Infect Dis; 2012 Feb; 12():37. PubMed ID: 22325147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.
    Hazbón MH; Brimacombe M; Bobadilla del Valle M; Cavatore M; Guerrero MI; Varma-Basil M; Billman-Jacobe H; Lavender C; Fyfe J; García-García L; León CI; Bose M; Chaves F; Murray M; Eisenach KD; Sifuentes-Osornio J; Cave MD; Ponce de León A; Alland D
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2640-9. PubMed ID: 16870753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China.
    Liu Y; Sun Y; Zhang X; Zhang Z; Xing Q; Ren W; Yao C; Yu J; Ding B; Wang S; Li C
    Epidemiol Infect; 2021 Jan; 149():e21. PubMed ID: 33397543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion.
    Click ES; Kurbatova EV; Alexander H; Dalton TL; Chen MP; Posey JE; Ershova J; Cegielski JP
    J Infect Dis; 2020 Jun; 221(12):2072-2082. PubMed ID: 32002554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
    PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco.
    Chaoui I; Sabouni R; Kourout M; Jordaan AM; Lahlou O; Elouad R; Akrim M; Victor TC; El Mzibri M
    J Infect Dev Ctries; 2009 May; 3(4):278-84. PubMed ID: 19759491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia.
    Narmandakh E; Tumenbayar O; Borolzoi T; Erkhembayar B; Boldoo T; Dambaa N; Burneebaatar B; Nymadawa N; Mitarai S; Jav S; Chiang CY
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
    Nguyen HQ; Nguyen NV; Contamin L; Tran THT; Vu TT; Nguyen HV; Nguyen NLT; Nguyen ST; Dang AD; Bañuls AL; Nguyen VAT
    Infect Genet Evol; 2017 Jun; 50():55-61. PubMed ID: 28214557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.
    Yao C; Zhu T; Li Y; Zhang L; Zhang B; Huang J; Fu W
    Clin Microbiol Infect; 2010 Nov; 16(11):1639-43. PubMed ID: 20491829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
    PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
    Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis.
    Fenner L; Egger M; Bodmer T; Altpeter E; Zwahlen M; Jaton K; Pfyffer GE; Borrell S; Dubuis O; Bruderer T; Siegrist HH; Furrer H; Calmy A; Fehr J; Stalder JM; Ninet B; Böttger EC; Gagneux S;
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3047-53. PubMed ID: 22470121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.